Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration

Leukemia. 2004 Mar;18(3):645-6. doi: 10.1038/sj.leu.2403251.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / pathology
  • Male
  • Middle Aged
  • Piperazines / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pulmonary Alveoli / pathology*
  • Pulmonary Eosinophilia / etiology
  • Pulmonary Eosinophilia / pathology*
  • Pulmonary Fibrosis / etiology
  • Pulmonary Fibrosis / pathology*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases